Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1980 1
1982 2
1983 2
1984 4
1985 1
1987 5
1988 7
1989 10
1990 6
1991 10
1992 9
1993 9
1994 15
1995 27
1996 20
1997 34
1998 30
1999 16
2000 33
2001 32
2002 26
2003 39
2004 42
2005 52
2006 55
2007 47
2008 44
2009 48
2010 38
2011 30
2012 42
2013 44
2014 29
2015 35
2016 43
2017 35
2018 38
2019 31
2020 31
2021 32
2022 37
2023 11

Text availability

Article attribute

Article type

Publication date

Search Results

1,028 results

Results by year

Filters applied: . Clear all
Page 1
Von Hippel-Lindau Syndrome.
Ben-Skowronek I, Kozaczuk S. Ben-Skowronek I, et al. Horm Res Paediatr. 2015;84(3):145-52. doi: 10.1159/000431323. Epub 2015 Aug 5. Horm Res Paediatr. 2015. PMID: 26279462 Free article. Review.
Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome characterized by the development of multiple vascular tumours. ...The course of VHL syndrome is associated with the development of multiple vascular tumours. ...
Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome characterized by the development of multi …
Von Hippel-Lindau disease.
Chittiboina P, Lonser RR. Chittiboina P, et al. Handb Clin Neurol. 2015;132:139-56. doi: 10.1016/B978-0-444-62702-5.00010-X. Handb Clin Neurol. 2015. PMID: 26564077 Free PMC article. Review.
von Hippel-Lindau (VHL) disease is an inheritable condition with an incidence of 1 in 36000 live births. ...In this chapter, we summarize the current state of knowledge in VHL disease....
von Hippel-Lindau (VHL) disease is an inheritable condition with an incidence of 1 in 36000 live births. ...In t …
Belzutifan: First Approval.
Deeks ED. Deeks ED. Drugs. 2021 Nov;81(16):1921-1927. doi: 10.1007/s40265-021-01606-x. Drugs. 2021. PMID: 34613603 Review.
Belzutifan (Welireg) is an oral small molecule inhibitor of hypoxia-inducible factor (HIF)-2alpha being developed by Peloton Therapeutics for the treatment of solid tumours, including renal cell carcinoma (RCC) with clear cell histology (ccRCC) and von Hippel-Lin …
Belzutifan (Welireg) is an oral small molecule inhibitor of hypoxia-inducible factor (HIF)-2alpha being developed by Peloton Therapeutics fo …
VHL, the story of a tumour suppressor gene.
Gossage L, Eisen T, Maher ER. Gossage L, et al. Nat Rev Cancer. 2015 Jan;15(1):55-64. doi: 10.1038/nrc3844. Nat Rev Cancer. 2015. PMID: 25533676 Review.
Since the Von Hippel-Lindau (VHL) disease tumour suppressor gene VHL was identified in 1993 as the genetic basis for a rare disorder, it has proved to be of wide medical and scientific interest. ...As our understanding of the importance of VHL matures, …
Since the Von Hippel-Lindau (VHL) disease tumour suppressor gene VHL was identified in 1993 as the genetic basis …
VON HIPPEL-LINDAU DISEASE: Update on Pathogenesis and Systemic Aspects.
Aronow ME, Wiley HE, Gaudric A, Krivosic V, Gorin MB, Shields CL, Shields JA, Jonasch EW, Singh AD, Chew EY. Aronow ME, et al. Retina. 2019 Dec;39(12):2243-2253. doi: 10.1097/IAE.0000000000002555. Retina. 2019. PMID: 31095066 Review.
METHODS: A PubMed search of the English language literature was reviewed using the following search terms: von Hippel-Lindau, von Hippel-Lindau disease, and VHL. Of 6,696 publications, the most current and pertinent information rel …
METHODS: A PubMed search of the English language literature was reviewed using the following search terms: von Hippel-Linda …
Von Hippel-Lindau disease: insights into oxygen sensing, protein degradation, and cancer.
Kaelin WG Jr. Kaelin WG Jr. J Clin Invest. 2022 Sep 15;132(18):e162480. doi: 10.1172/JCI162480. J Clin Invest. 2022. PMID: 36106637 Free PMC article. Review.
Germline loss-of-function mutations of the VHL tumor suppressor gene cause von Hippel-Lindau disease, which is associated with an increased risk of hemangioblastomas, clear cell renal cell carcinomas (ccRCCs), and paragangliomas. ...Five of these agent …
Germline loss-of-function mutations of the VHL tumor suppressor gene cause von Hippel-Lindau disease, which is a …
Belzutifan: A Narrative Drug Review.
Visweswaran V, Pavithran K. Visweswaran V, et al. Curr Drug Res Rev. 2022;14(2):88-95. doi: 10.2174/2589977514666220401094724. Curr Drug Res Rev. 2022. PMID: 35366789 Review.
This disease results from loss of function mutations in the tumour suppressor gene known as the Von Hippel-Lindau gene, located on chromosome 3. ...Belzutifan showed clinically meaningful response rates for both Von Hippel-Lindau …
This disease results from loss of function mutations in the tumour suppressor gene known as the Von Hippel-Lindau …
Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.
Rednam SP, Erez A, Druker H, Janeway KA, Kamihara J, Kohlmann WK, Nathanson KL, States LJ, Tomlinson GE, Villani A, Voss SD, Schiffman JD, Wasserman JD. Rednam SP, et al. Clin Cancer Res. 2017 Jun 15;23(12):e68-e75. doi: 10.1158/1078-0432.CCR-17-0547. Clin Cancer Res. 2017. PMID: 28620007 Review.
Von Hippel-Lindau disease (vHL) is a hereditary tumor predisposition syndrome that places affected individuals at risk for multiple tumors, which are predominantly benign and generally occur in the central nervous system or abdomen. ...Another n …
Von Hippel-Lindau disease (vHL) is a hereditary tumor predisposition syndrome that places affected indivi …
The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis.
Hudler P, Urbancic M. Hudler P, et al. Genes (Basel). 2022 Feb 17;13(2):362. doi: 10.3390/genes13020362. Genes (Basel). 2022. PMID: 35205407 Free PMC article. Review.
Von Hippel-Lindau disease (VHL disease or VHL syndrome) is a familial multisystem neoplastic syndrome stemming from germline disease-associated variants of the VHL tumor suppressor gene on chromosome 3. ...VHL variations hav …
Von Hippel-Lindau disease (VHL disease or VHL syndrome) is a familial multisystem neoplastic sy …
MANAGEMENT OF RETINAL HEMANGIOBLASTOMA IN VON HIPPEL-LINDAU DISEASE.
Wiley HE, Krivosic V, Gaudric A, Gorin MB, Shields C, Shields J, Aronow ME, Chew EY. Wiley HE, et al. Retina. 2019 Dec;39(12):2254-2263. doi: 10.1097/IAE.0000000000002572. Retina. 2019. PMID: 31259811 Free PMC article. Review.
PURPOSE: To review the current state of diagnosis and management of retinal hemangioblastoma and retinal vascular proliferation arising from von Hippel-Lindau (VHL) disease. METHODS: A review of the literature was performed. Consensus was reached among …
PURPOSE: To review the current state of diagnosis and management of retinal hemangioblastoma and retinal vascular proliferation arising from …
1,028 results